Abstract
The objective of the study was to investigate the association between nephrolithiasis and the risk of chronic kidney disease (CKD). PubMed, Embase and ScienceDirect databases were searched for relevant cohort studies. A meta-analysis was conducted by pooling data from these studies via an inverse variance method. The Q statistic and I 2 were used to measure heterogeneity. Sensitivity analysis was conducted to ascertain whether the results were stable. Nine studies with eight cohorts involving 4,770,691 participants were identified. Compared to individuals without a history of nephrolithiasis, the pooled relative risk was 1.52 [95% confidence interval (CI) 1.24, 1.68; I 2 = 93.7%] for all stages of CKD and 2.16 (95% CI 1.83–2.54; I 2 = 0.00%) for end-stage kidney disease. Publication bias was not detected. Sensitivity analysis indicated that the results were stable. Nephrolithiasis may increase the risk of CKD, regardless of the patient population (region), and may be an important risk factor for end-stage kidney disease.
Similar content being viewed by others
References
Türk C, Petřík A, Sarica K et al (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69(3):468–474
Cheungpasitporn W, Thongprayoon C, Mao MA et al (2014) The risk of coronary heart disease in patients with kidney stones: a systematic review and meta-analysis. N Am J Med Sci 6(11):580–585
National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266
Chen N, Wang W, Huang Y et al (2009) Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24(7):2117–2123
Ingsathit A, Thakkinstian A, Chaiprasert A et al (2010) Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 25(5):1567–1575
Vupputuri S, Soucie JM, McClellan W et al (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14(3):222–228
Marangella M, Bruno M, Cosseddu D et al (1990) Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron 4(4):302–306
Hippisley-Cox J, Coupland C (2010) Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 21(11):49
Kummer AE, Grams M, Lutsey P et al (2015) Nephrolithiasis as a risk factor for CKD: the atherosclerosis risk in communities study. Clin J Am Soc Nephrol 10(11):2023–2029
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269
Bekkering GE, Harris RJ, Thomas S et al (2008) How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol 167(9):1017–1026
Wells GA, Shea B, O’Connell D et al (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed Dec 2014
Aune D, Lau R, Chan DSM et al (2011) Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 141(1):16–20
Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration, 5.1.0 edn. http://www.cochrane-handbook.org. Accessed 23 May 2016
Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Rule AD, Bergstralh EJ, Melton LJ et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4(4):804–811
El-Zoghby ZM, Lieske JC, Foley RN et al (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415
Shoag J, Halpern J, Goldfarb DS et al (2014) Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol 192(5):1440–1445
Alexander RT, Hemmelgarn BR, Wiebe N et al (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287
D’Costa M, Savcic-Kos R, Huang J et al (2016) Urological procedures in urolithiasis and their association with chronic kidney disease. Clin Med Res 14(2):75–82
Keller JJ, Chen YK, Lin HC (2012) Association between chronic kidney disease and urinary calculus by stone location: a population-based study. BJU Int 110(11 Pt C):E1074–E1078
Ando R, Nagaya T, Suzuki S et al (2014) MP34-15 increased risk for chronic kidney disease in kidney stone formers: a follow-up study in Japanese. Urolithiasis 6(42):498
Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324
Türk C, Petřík A, Sarica K et al (2016) EAU guidelines on interventional treatment for urolithiasis. Eur Urol 69(3):475–482
Lieske JC, Peña de la Vega LS, Slezak JM et al (2006) Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69(4):760–764
Zhang L, Wang F, Wang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815–822
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhe, M., Hang, Z. Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants. Urolithiasis 45, 441–448 (2017). https://doi.org/10.1007/s00240-016-0938-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-016-0938-x